|Title||Hypes and hopes of the artficial pancreas|
|Lectures||Current automated insulin delivery systems : what do they really achieve ?
Patient-driven R&D : why-how-what ?
What will it take to address uncontrolled diabetes with closed-loop technology ?
Risk-benefit assessment of beta-cell replacement vs automated insulin delivery systems
|Why you should attend||As automated insulin delivery (AID) devices are about to hit the market, it is timely to review what they are actually able to achieve and how they compare with current biological beta cell replacement therapies.|
|What you will learn||What is the current state-of-the-art in automated insulin delivery systems
What are the technological issues to solve or improve
How does AID benchmark against beta-cell replacement therapies